T1	Participants 83 120	patients with chronic kidney disease.
T2	Participants 750 868	subgroup of patients from a study that evaluated the impact of two phosphorus binder regimens on hard outcomes in CKD.
T3	Participants 869 958	Patients (n = 113) with stage 3-4 CKD and evidence of CAC on a phosphorus-restricted diet
